Kiroma BioPharma, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, July 29, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kiroma BioPharma, Inc. ("Kiroma" or the "Company") (NASDAQ: KRBP) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.